An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120
NCT ID: NCT04814914
Last Updated: 2021-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
333 participants
OBSERVATIONAL
2021-03-25
2021-05-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER
NCT04341142
Long-term Follow-up Study of COVID-19
NCT05986435
Leflunomide in Mild COVID-19 Patients
NCT04361214
A COVID-19 Symptom, Exposure and Immune Response Registry
NCT04348942
Low-Dose Chest CT (LDCT) COVID-19 Study
NCT05031845
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
KB109 + Self Supportive Care (SSC)
KB109 + Self Supportive Care
KB109 is a novel glycan
Self Supportive Care (SSC) Alone
Self Supportive Care (SSC) Alone
Self Supportive Care (SSC) Alone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
KB109 + Self Supportive Care
KB109 is a novel glycan
Self Supportive Care (SSC) Alone
Self Supportive Care (SSC) Alone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have been randomized in either the K031-120 or K032-120 study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaleido Biosciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Wingertzahn, PhD
Role: STUDY_DIRECTOR
Kaleido Biosciences, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HealthStar Research, LLC
Hot Springs, Arkansas, United States
Quad Clinical Research
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K034-120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.